Meddenovo Drug Design
PrivateLast Round
Pre Seed
Jul 31, 2024
Total Funding Raised
$1.08M
Momentum Score
50 /100
Company Overview
Meddenovo Drug Design is a biotechnology company that develops an AI-powered platform for the de novo design of cyclic peptides to accelerate drug discovery.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Subscription SaaS, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Meddenovo Drug Design Comps
Public and private peers based on sector, stage, and business model.
Meddenovo Drug Design Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Jul 31, 2024 |
Key People
Founding team and executive leadership
Meddenovo Drug Design Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ACT Venture Partners | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 5, 2026
Monthly visitors increased 270% MoM.
- Apr 10, 2025
Grew 60% QoQ from 5 to 8 employees.
Meddenovo Drug Design Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Meddenovo Drug Design's valuation, stock price, and market status.
